Drug Monitoring, Pregabalin, Quantitative, with medMATCH, Urine

Clinical Significance

 Drug Monitoring, Pregabalin, Quantitative, with medMATCH, Urine - The management of patients use of controlled substances is an increasing focus of law enforcement to ensure that prescribed medications arent diverted, and is critical to the successful outcome of many pharmaco-therapies. Urine drug testing for the presence or absence of prescribed medications and illicit drugs is a strategy designed to help the treating physician monitor their patients for compliance with that physicians directive(s).

Client Notes

 Please contact 266-1500 (Option 1) to acquire the appropriate specimen type

Specimen Requirements

20.0 mL Urine in a Green Clinical Drug Test Collection Cup

Transport And Storage

14 days Ambient
14 days Refrigerated
30 days Frozen

Transport Ambient

Collection Instructions

Minimum Volume

7.0 mL Urine

Neonatal Volume

Reference Range:

Pregabalin <1000 ng/mL

Methodology:

• Mass Spectrometry (MS)

Clinical Significance

 Drug Monitoring, Pregabalin, Quantitative, with medMATCH, Urine - The management of patients use of controlled substances is an increasing focus of law enforcement to ensure that prescribed medications arent diverted, and is critical to the successful outcome of many pharmaco-therapies. Urine drug testing for the presence or absence of prescribed medications and illicit drugs is a strategy designed to help the treating physician monitor their patients for compliance with that physicians directive(s).

CDM

00918064

CPT Coding

80366; G0480

Medical Necessity May Apply

Medical Necessity Documentation

G0480 - may need ABN